Result
€1.4m ▲ 172%
The result rose in 2019: 12-month financial year.
STASISPORT PHARMA
abbreviatedSP PHARMALifetime
10 annual accounts with figures on one time axispeak €1.0m (2017)
-not published
lowest -€501,010 (2009)
€1.4m▲ 172%
peak €3.2m (2019)
€3.2m▲ 81.4%
€832,730▲ 450%
Board4 names since 2020
-
Owners2 names in the annual accounts
100%A.forall Development and 1 other
Documentsfilings and deeds
14-07-202017 days before the deadline
2019abbreviated format
Result from €525,610 to €1.4mEquity from €1.8m to €3.2mDebts from €151,494 to €832,730Investments €272,327Cash from €4,910 to €616,762
Key points
from the 2019 annual accounts, the last ones filedLiquidity
4.08 was 9.55 in 2018
Short-term debts rose from €151,494 to €832,730.
Filings
10 annual accounts 11 filings, 4 late
The 2013 accounts came latest: 428 days after the end of the period.
No score
Board and ownership
last known boardGI
GRNR Invest BV
Director, until 2020
- Alter Pharma Group NV consolidatesequity €127.0m (2024) · annual accounts 2019
Recent changes
Merger: absorbed by Neogen
Dissolution of the company · Dissolved without liquidation · Appointment: Deloitte Bedrijfsrevisoren (statutory auditor) · General meeting of 30-06-2020 · Gazette deed
2 directors appointed, 2 resignations
Resignations: GRNR Invest BV and Alter Pharma NV · Permanent representatives: Thomas Jacobsen, PVR Invest BV, Pieter Van Rompay, Ivo Peeters and Erik Voets · Appointments: Jacobsen Management BV and HFS BV · General meeting of 12-02-2020 · Gazette deed
Incorporation
13 publications in the Belgian Official Gazette, the last on 23-07-2020 · Gazette deed
Official details
Source: KBO- Status
- Absorbed by Neogen NVmerger by absorption, July 2020
- Activity
- “Alle industriële,commerciële verrichtingen met betrekking tot de ontwikkeling en commercialisatie van fytofarmaceutische,farmaceutische,dieetvoeding- en cosmeticaproducten.” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on STASISPORT PHARMA
Absorbed by Neogen NV in July 2020. The last annual accounts are for financial year 2019. The company was dissolved without liquidation.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about STASISPORT PHARMA
- What is the company number of STASISPORT PHARMA?
- The company number of STASISPORT PHARMA is 0898.168.530. The VAT number is the same number with BE in front: BE 0898.168.530.
- What is the legal form of STASISPORT PHARMA?
- Legal form of STASISPORT PHARMA: NV.
- Is STASISPORT PHARMA still active?
- No. STASISPORT PHARMA is inactive in the KBO register.Company details
- What is the turnover of STASISPORT PHARMA?
- The turnover in financial year 2019 is ≈ €3.1m. This figure is estimated from the gross margin of €1.8m and 1,585 comparable companies of the same size. It probably lies between €2.1m and €5.1m. It is a rough estimate. In financial year 2018 turnover was €810,786.Financials
- Is STASISPORT PHARMA profitable?
- In financial year 2019, STASISPORT PHARMA made a profit of €1.4m.
- Where can I find the annual accounts of STASISPORT PHARMA?
- STASISPORT PHARMA filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2019.